About Eli Lilly and Company
Eli Lilly is a pharmaceutical company based in Indianapolis, Indiana, that discovers, makes, and sells prescription medicines worldwide. Its biggest growth drivers are Mounjaro and Zepbound, treatments for diabetes and obesity, along with the cancer drug Verzenio. The company also sells medicines across heart and metabolic health, oncology, immunology, and neuroscience. David Ricks serves as chief executive. Lilly was founded in 1876 and sells its products in about 125 countries, and its diabetes and weight-loss treatments have become a major focus of the business.
Walmart and Eli Lilly reject OKXICE tokenized stock plans as objections reach 38
Corporate resistance to OKXICE's tokenized stock plans highlights broader concerns about third-party control and the future of blockchain securities.
Nvidia and Eli Lilly commit up to $1B to AI drug discovery lab
The collaboration could revolutionize drug discovery, enhancing AI's role in life sciences and potentially accelerating medical breakthroughs.
Isomorphic Labs reportedly seeks funding at a valuation of at least $40 billion
Isomorphic Labs' valuation surge highlights the growing investor confidence in AI-driven drug discovery, despite lacking clinical data.
Novo Nordisk partners with Anthropic to accelerate drug discovery
Novo's AI partnership could revolutionize drug development, potentially reducing timelines and costs, while intensifying industry competition.
Dell COO reports customer count surpasses 6,500 amid broadening demand
Dell's rapid AI customer growth highlights a booming demand that could strain supply chains, impacting revenue realization and market dynamics.
Solana’s tokenized equity market reaches $465M as Sunrise lists healthcare stocks
Solana's dominance in tokenized equities highlights DeFi's potential to revolutionize traditional finance with 24/7 trading and composability.
A sourced map of Eli Lilly and Company's relationships is on the way.
Partners, competitors and related assets, each link independently verified and source-linked before it appears here.
The Crypto Briefing podcast is on the way.
Conversations on Eli Lilly and Company and the wider market, hosted by our team, will appear here once episodes are live.